PULSE BIOSCIENCES, INC. — Director's Dealing 2020

Aug 10, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2020-08-06

Reporting Person: van den Broek Richard (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-06	Stock Option (right to buy)	$10.78	A	32500	Acquired	2030-08-06	Common Stock (32500)	Direct

Footnotes

F1: One-third (1/3) of the shares subject to the option will vest on August 6, 2021, and the remaining shares will vest in equal monthly installments thereafter over the following two year period, subject to the Reporting Person's continued service through each vesting date.